Print Page  Close Window

SEC Filings

S-1
VITAE PHARMACEUTICALS, INC filed this Form S-1 on 08/12/2014
Entire Document
 

Table of Contents


VITAE PHARMACEUTICALS, INC.
Index to Financial Statements

 
  Page  

Audited Financial Statements for the Years Ended December 31, 2013 and 2012:

       

Report of Independent Registered Public Accounting Firm

   
F-2
 

Balance Sheets as of December 31, 2013 and 2012

   
F-3
 

Statements of Operations for the Years Ended December 31, 2013 and 2012

   
F-4
 

Statements of Comprehensive Income for the Years Ended December 31, 2013 and 2012

   
F-5
 

Statements of Convertible Preferred Stock and Stockholders' Deficit for the Years Ended December 31, 2013 and 2012

   
F-6
 

Statements of Cash Flows for the Years Ended December 31, 2013 and 2012

   
F-7
 

Notes to Financial Statements

   
F-8
 

Unaudited Condensed Financial Statements for the Six Months Ended June 30, 2014 and 2013:

   
 
 

Condensed Balance Sheets as of June 30, 2014 (Unaudited) and December 31, 2013

   
F-33
 

Unaudited Condensed Statements of Operations for the Six Months Ended June 30, 2014 and 2013

   
F-34
 

Unaudited Condensed Statements of Comprehensive Loss for the Six Months Ended June 30, 2014 and 2013

   
F-35
 

Unaudited Condensed Statements of Cash Flows for the Six Months Ended June 30, 2014 and 2013

   
F-36
 

Notes to Unaudited Condensed Financial Statements

   
F-37
 

F-1